Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Continuous subcutaneous insulin infusion]

H Ito1, A Kanatsuka

  • 1Second Department of Internal Medicine, Chiba University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 10, 1997
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The dipeptidyl peptidase-4 inhibitor vildagliptin has the capacity to repair β-cell dysfunction and insulin resistance.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2014
Same author

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with α-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): a multicenter, randomized, open-label, non-inferiority trial.

Diabetes, obesity & metabolism·2014
Same author

Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy--a nationwide 5-year-study in Japan.

Diabetologia·2007
Same author

Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy.

The Journal of clinical endocrinology and metabolism·2005
Same author

Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus.

Diabetologia·2005
Same author

A patient with subcutaneous-insulin resistance treated by insulin lispro plus heparin.

Diabetes research and clinical practice·2001